RET and sarcoma: The expression levels of sunitinib targeted-kinases were measured by transcriptome sequencing for PDGFRA/B, KIT, RET, FLT1(VEGFR1), KDR (VEGFR2), and FLT4(VEGFR3) (Figure 3) for patient cohort with EMC and other sarcoma histologies.